SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950144-04-008627
Filing Date
2004-08-26
Accepted
2004-08-26 15:33:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 NOVAVAX, INC. - FORM SC 13D/A g90176sc13dza.htm SC 13D/A 32411
2 EX-1 EXCHANGE AGREEMENT g90176exv1.txt EX-1 102606
3 EX-2 TERMINATION AGREEMENT g90176exv2.txt EX-2 21446
4 EX-3 REGISTRATION RIGHTS AGREEMENT g90176exv3.txt EX-3 50664
  Complete submission text file 0000950144-04-008627.txt   209599
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Subject) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48948 | Film No.: 04998912
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filed by) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations